Loading...
XWAR
ENE
Market cap142mUSD
Jul 09, Last price  
19.00PLN
1D
0.00%
1Q
-3.55%
Jan 2017
95.88%
IPO
280.00%
Name

Centrum Medyczne Enel Med SA

Chart & Performance

D1W1MN
XWAR:ENE chart
P/E
41.68
P/S
0.63
EPS
0.46
Div Yield, %
Shrs. gr., 5y
3.71%
Rev. gr., 5y
16.40%
Revenues
854m
+16.13%
137,803,000166,289,000180,785,000199,760,000213,676,000234,658,000273,702,000323,728,000371,712,000417,691,000399,798,000441,144,000494,904,000618,546,000735,594,000854,268,000
Net income
13m
-11.75%
969,0004,087,000-8,831,000467,00041,544,000557,0001,833,000-3,306,000-735,000-2,468,000-3,396,000-1,410,000-23,558,0008,229,00014,609,00012,892,000
CFO
99m
-3.75%
9,940,00012,581,00011,052,00017,451,00012,374,00015,993,00017,216,00023,990,00014,939,00074,801,00074,366,00067,171,00040,048,00081,022,000103,261,00099,391,000
Dividend
Jun 09, 20150.1 PLN/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Centrum Medyczne ENEL-MED S.A., a prominent healthcare provider established in 1993, operates from its Warsaw, Poland base, offering an extensive array of medical services nationwide. These provisions encompass specialized consultations, dentistry, orthopedics, infertility treatments, physical rehabilitation, psychological support, and comprehensive diagnostic capabilities. Additionally, they provide vaccinations, emergency care, and surgical interventions to their patients.
IPO date
Jun 14, 2011
Employees
4,164
Domiciled in
PL
Incorporated in
PL

Valuation

Title
PLN in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT